EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Does Dialysis Type Matter? Re-Evaluating Prognosis in UTUC Patients Following Surgery

Yi-Ying Hsieh iD, I-Hsuan Alan Chen, Chia-Cheng Yu iD, Chao-Hsiang Chang, Chin-Chung Yeh, Wei-Ming Li, Hung-Lung Ke, Bor-En Jong, Yi-Ju Chou iD, Chung-You Tsai iD, Pai-Yu Cheng, Marcelo Chen und 3 weitere

Cancers · 18.08.2026 · 18 (16) · 2670

DOI: 10.3390/cancers18162670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.08.2026. Verfasst von Yi-Ying Hsieh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Taiwan University Hospital, Taipei 100225, Taiwan. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with end-stage renal disease (ESRD) undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) represent a uniquely high-risk population. While prior studies have demonstrated worse postoperative outcomes among dialysis-dependent patients, no study has systematically compared oncological outcomes between peritoneal dialysis (PD) and hemodialysis (HD) modalities following RNU. This multicenter study evaluates whether dialysis modality (peritoneal dialysis versus hemodialysis) acts as an independent prognostic factor following radical nephroureterectomy.

Methods

Using the Taiwan UTUC Collaboration Group Registry—a multicenter, nationwide database comprising 21 tertiary and regional medical centers —we identified 350 ESRD patients who underwent RNU for UTUC between September 1988 and December 2023. Patients were categorized by dialysis modality at the time of surgery: 310 on HD and 40 on PD. Propensity score overlap weighting was applied to account for baseline differences. Multivariate Cox proportional hazards and Fine-Gray competing risk regression models were utilized to evaluate overall survival (OS), cancer-specific survival (CSS), progression-free survival (PFS), and non-UTUC mortality.

Results

After overlap weighting, PD was independently associated with significantly worse OS (HR = 2.34, 95% CI 1.29–4.25, p = 0.005) and PFS (HR = 2.06, 95% CI 1.16–3.66, p = 0.013) compared to HD and exhibited a trend toward worse CSS in univariate analysis (log-rank p = 0.094). Survival curve divergence between PD and HD was most pronounced from 12 to 24 months post-surgery onward. Notably, this survival disadvantage persisted despite PD patients being significantly younger (mean age 58.8 vs. 65.1 years) and receiving adjuvant chemotherapy more frequently (20.0% vs. 6.5%). PD was also independently associated with higher non-UTUC mortality on multivariate competing risk analysis (sHR = 2.17, 95% CI 1.22–3.88, p = 0.009).

Conclusions

In this first multicenter systematic comparison of PD versus HD patients undergoing RNU for UTUC, PD modality was independently associated with worse OS and PFS and exhibited a trend toward worse CSS in univariate analysis, compared to HD. This survival disadvantage persists despite favorable baseline characteristics and higher rates of adjuvant chemotherapy. We hypothesize these outcomes may be driven by a dual vulnerability: impaired systemic tumor control and elevated non-cancer mortality following surgical disruption of the peritoneal environment. To mitigate these risks, prioritizing minimally invasive or retroperitoneal surgical approaches to preserve peritoneal integrity, combined with modality-specific multidisciplinary surveillance, is recommended.

Schlagwörter

Stichwörter der Autor:innen

hemodialysisperioneal dialysispropensity scoreradical nephroureterectomysurvivalupper tract urothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, National Taiwan University Hospital, Taipei 100225, Taiwan.
  • Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City 231057, Taiwan.
  • Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.
  • Department of Urology, China Medical University and Hospital, Taichung 404327, Taiwan.
  • School of Medicine, China Medical University, Taichung 404333, Taiwan.
  • Department of Urology, Kaohsiung Medical University Gangshan Hospital, Kaohsiung 820004, Taiwan.

ORCID-Profile: Yi-Ying Hsieh, Chia-Cheng Yu, Yi-Ju Chou, Chung-You Tsai, Vincent F S Tsai, Yao-Chou Tsai

Zitieren

APA

Hsieh, Y. Y., Chen, I. A., Yu, C. C., Chang, C. H., Yeh, C. C., Li, W. M., Ke, H. L., Jong, B. E., Chou, Y. J., Tsai, C. Y., Cheng, P. Y., Chen, M., Lin, W. R., Tsai, V. F. S., & Tsai, Y. C. (2026). Does Dialysis Type Matter? Re-Evaluating Prognosis in UTUC Patients Following Surgery. Cancers, 18(16), 2670. https://doi.org/10.3390/cancers18162670

Vancouver

Hsieh YY, Chen IA, Yu CC, Chang CH, Yeh CC, Li WM, et al. Does Dialysis Type Matter? Re-Evaluating Prognosis in UTUC Patients Following Surgery. Cancers. 2026;18(16):2670. doi:10.3390/cancers18162670

BibTeX
@article{Hsieh2026,
  author = {Hsieh, Yi-Ying and Chen, I-Hsuan Alan and Yu, Chia-Cheng and Chang, Chao-Hsiang and Yeh, Chin-Chung and Li, Wei-Ming and Ke, Hung-Lung and Jong, Bor-En and Chou, Yi-Ju and Tsai, Chung-You and Cheng, Pai-Yu and Chen, Marcelo and Lin, Wun-Rong and Tsai, Vincent F S and Tsai, Yao-Chou},
  title = {Does Dialysis Type Matter? Re-Evaluating Prognosis in UTUC Patients Following Surgery},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {2670},
  doi = {10.3390/cancers18162670}
}
Kostenlos starten →